Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Benzhen Pharmaceutical, formerly known as Jiangxi Chengzhi Xinfeng Pharmaceutical, is a pharmaceutical manufacturing company based in Xinfeng County, Jiangxi Province, China. Following its acquisition by the Jiangxi Oushi Group in 2010, the company was renamed and integrated into the group's broader healthcare operations. It specializes in the production of a wide range of pharmaceutical products, including small molecule drugs and traditional Chinese patent medicines. The company's portfolio features well-known products such as Compound Ganmaoling Tablets for the common cold and Compound Chenxiang Wei Tablets for gastrointestinal issues. Benzhen Pharmaceutical maintains GMP-certified production lines for various dosage forms, including tablets, granules, and small-volume injections, primarily serving the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengzhi Xinfeng Pharmaceutical Jiangxi.